RYAN DHINDSA to Humans
This is a "connection" page, showing publications RYAN DHINDSA has written about Humans.
Connection Strength
0.254
-
Rare variant associations with plasma protein levels in the UK Biobank. Nature. 2023 Oct; 622(7982):339-347.
Score: 0.024
-
Studying ultra-rare variants in STX1A uncovers a novel neurodevelopmental disorder. Eur J Hum Genet. 2023 09; 31(9):973-974.
Score: 0.024
-
A minimal role for synonymous variation in human disease. Am J Hum Genet. 2022 12 01; 109(12):2105-2109.
Score: 0.023
-
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis. Commun Biol. 2021 03 23; 4(1):392.
Score: 0.020
-
A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders. Ann Neurol. 2021 02; 89(2):199-211.
Score: 0.020
-
Natural Selection Shapes Codon Usage in the Human Genome. Am J Hum Genet. 2020 07 02; 107(1):83-95.
Score: 0.019
-
Schizophrenia: From genetics to physiology at last. Nature. 2016 Feb 11; 530(7589):162-3.
Score: 0.014
-
Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies. Curr Neurol Neurosci Rep. 2015 Oct; 15(10):70.
Score: 0.014
-
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. Nat Commun. 2025 Feb 19; 16(1):1779.
Score: 0.007
-
Disease prediction with multi-omics and biomarkers empowers case-control genetic discoveries in the UK Biobank. Nat Genet. 2024 Sep; 56(9):1821-1831.
Score: 0.007
-
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences. Nat Genet. 2024 Sep; 56(9):1832-1840.
Score: 0.006
-
Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank data. Sci Adv. 2024 May 10; 10(19):eadj1424.
Score: 0.006
-
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency. PLoS Genet. 2023 Oct; 19(10):e1010952.
Score: 0.006
-
Literature-based predictions of Mendelian disease therapies. Am J Hum Genet. 2023 10 05; 110(10):1661-1672.
Score: 0.006
-
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank. Am J Hum Genet. 2023 03 02; 110(3):487-498.
Score: 0.006
-
DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Commun Biol. 2022 11 24; 5(1):1291.
Score: 0.006
-
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci Adv. 2022 11 18; 8(46):eadd5430.
Score: 0.006
-
Cancer-driving mutations are enriched in genic regions intolerant to germline variation. Sci Adv. 2022 08 26; 8(34):eabo6371.
Score: 0.006
-
Ancestry adjustment improves genome-wide estimates of regional intolerance. Genetics. 2022 05 31; 221(2).
Score: 0.006
-
Association of ultra-rare coding variants with genetic generalized epilepsy: A case-control whole exome sequencing study. Epilepsia. 2022 03; 63(3):723-735.
Score: 0.005
-
High-impact rare genetic variants in severe schizophrenia. Proc Natl Acad Sci U S A. 2021 12 21; 118(51).
Score: 0.005
-
Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021 09; 597(7877):527-532.
Score: 0.005
-
Prioritizing non-coding regions based on human genomic constraint and sequence context with deep learning. Nat Commun. 2021 03 08; 12(1):1504.
Score: 0.005
-
Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics. PLoS One. 2017; 12(8):e0181604.
Score: 0.004
-
Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med. 2015 Oct; 17(10):774-81.
Score: 0.003